188 related articles for article (PubMed ID: 33985905)
1. Validation of a machine learning approach using FIB-4 and APRI scores assessed by the metavir scoring system: A cohort study.
Hashem A; Awad A; Shousha H; Alakel W; Salama A; Awad T; Mabrouk M
Arab J Gastroenterol; 2021 Jun; 22(2):88-92. PubMed ID: 33985905
[TBL] [Abstract][Full Text] [Related]
2. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients.
Wang CC; Liu CH; Lin CL; Wang PC; Tseng TC; Lin HH; Kao JH
J Formos Med Assoc; 2015 Oct; 114(10):923-8. PubMed ID: 26279173
[TBL] [Abstract][Full Text] [Related]
4. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
[TBL] [Abstract][Full Text] [Related]
5. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
6. Validation of APRI and FIB-4 score in an Antwerp cohort of chronic hepatitis C patients.
Verlinden W; Bourgeois S; De Maeyer M; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
Acta Gastroenterol Belg; 2015 Dec; 78(4):373-80. PubMed ID: 26712046
[TBL] [Abstract][Full Text] [Related]
7. Does Incorporating Change in APRI or FIB-4 Indices Over Time Improve the Accuracy of a Single Index for Identifying Liver Fibrosis in Persons With Chronic Hepatitis C Virus Infection?
Gounder PP; Haering C; Bruden DJT; Townshend-Bulson L; Simons BC; Spradling PR; McMahon BJ
J Clin Gastroenterol; 2018 Jan; 52(1):60-66. PubMed ID: 27875352
[TBL] [Abstract][Full Text] [Related]
8. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran.
Moosavy SH; Eftekhar E; Davoodian P; Nejatizadeh A; Shadman M; Zare S; Nazarnezhad MA
BMC Gastroenterol; 2023 May; 23(1):145. PubMed ID: 37170243
[TBL] [Abstract][Full Text] [Related]
9. Aspartate aminotransferase to platelet ratio and fibrosis-4 as biomarkers in biopsy-validated pediatric cystic fibrosis liver disease.
Leung DH; Khan M; Minard CG; Guffey D; Ramm LE; Clouston AD; Miller G; Lewindon PJ; Shepherd RW; Ramm GA
Hepatology; 2015 Nov; 62(5):1576-83. PubMed ID: 26223427
[TBL] [Abstract][Full Text] [Related]
10. Multicenter validation of FIB-6 as a novel machine learning non-invasive score to rule out liver cirrhosis in biopsy-proven MAFLD.
Anushiravani A; Alswat K; Dalekos GN; Zachou K; Örmeci N; Al-Busafi S; Abdo A; Sanai F; Mikhail NN; Soliman R; Shiha G
Eur J Gastroenterol Hepatol; 2023 Nov; 35(11):1284-1288. PubMed ID: 37695595
[TBL] [Abstract][Full Text] [Related]
11. FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran.
Amernia B; Moosavy SH; Banookh F; Zoghi G
BMC Gastroenterol; 2021 Dec; 21(1):453. PubMed ID: 34861841
[TBL] [Abstract][Full Text] [Related]
12. Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C.
Cheng CH; Chu CY; Chen HL; Lin IT; Wu CH; Lee YK; Hu PJ; Bair MJ
J Microbiol Immunol Infect; 2020 Aug; 53(4):542-549. PubMed ID: 31831303
[TBL] [Abstract][Full Text] [Related]
13. Validation of aspartate aminotransferase to platelet ratio for diagnosis of liver fibrosis and prediction of postoperative prognosis in infants with biliary atresia.
Yang LY; Fu J; Peng XF; Pang SY; Gao KK; Chen ZR; He LJ; Wen Z; Wang H; Li L; Wang FH; Yu JK; Xu Y; Gong ST; Xia HM; Liu HY
World J Gastroenterol; 2015 May; 21(19):5893-900. PubMed ID: 26019453
[TBL] [Abstract][Full Text] [Related]
14. Correlation of APRI Index with Metavir Index in Children with Neonatal Cholestasis Without Biliary Atresia.
Shah I; Madgum N
Ann Hepatol; 2018 July - August ,; 17(4):592-595. PubMed ID: 29893700
[TBL] [Abstract][Full Text] [Related]
15. FIB-4 and APRI scores for predicting severe liver fibrosis in chronic hepatitis HCV patients: a monocentric retrospective study.
Catanzaro R; Aleo A; Sciuto M; Zanoli L; Balakrishnan B; Marotta F
Clin Exp Hepatol; 2021 Mar; 7(1):111-116. PubMed ID: 34027123
[TBL] [Abstract][Full Text] [Related]
16. Limited reliability of five non-invasive biomarkers in predicting hepatic fibrosis in chronic HCV mono-infected patients opposed to METAVIR scoring.
Elesawy BH; Abd El Hafez A; Dorgham LS; El-Askary A
Pathol Res Pract; 2014 Dec; 210(12):922-8. PubMed ID: 25123964
[TBL] [Abstract][Full Text] [Related]
17. Assessing significant fibrosis using imaging-based elastography in chronic hepatitis B patients: Pilot study.
Park HS; Choe WH; Han HS; Yu MH; Kim YJ; Jung SI; Kim JH; Kwon SY
World J Gastroenterol; 2019 Jul; 25(25):3256-3267. PubMed ID: 31333316
[TBL] [Abstract][Full Text] [Related]
18. Serum biomarkers predictive of cirrhosis in alcoholic liver disease as an alternative to ARFI-SW elastography.
Cioarca-Nedelcu R; Kundnani NR; Sharma A; Nistor D; Maghet E; Atanasiu V; Stoian I
Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5590-5595. PubMed ID: 37401296
[TBL] [Abstract][Full Text] [Related]
19. APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.
Yen YH; Kuo FY; Kee KM; Chang KC; Tsai MC; Hu TH; Lu SN; Wang JH; Hung CH; Chen CH
PLoS One; 2018; 13(6):e0199760. PubMed ID: 29953518
[TBL] [Abstract][Full Text] [Related]
20. Biopsy Validated Study of Biomarkers for Liver Fibrosis and Transplant Prediction in Inherited Cholestasis.
Shiau H; Guffey D; Loomes KM; Seidman C; Ragozzino E; Molleston JP; Schady D; Leung DH
Hepatol Commun; 2020 Oct; 4(10):1516-1526. PubMed ID: 33024920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
